Bronchodilator reversibility testing in morbidly obese non-smokers: a comparative study– few concerns

Document Type

Article

Publication Title

BMC Pulmonary Medicine

Abstract

This is a letter in response to an article by Ahmed et al., which concluded that in comparison to salbutamol, Fluticasone/salmeterol combination increases FEV1, FEV1% of predicted, and FEV1/FVC ratio, however it did not offer novel insights, as both agents met the 12%- and 200-mL reversibility benchmarks and Concerns about incorporating a combination medication that includes an inhaled corticosteroid, inhaled corticosteroids are not typically associated with bronchodilation.

DOI

10.1186/s12890-024-02951-9

Publication Date

12-1-2024

This document is currently not available here.

Share

COinS